INSYS Therapeutics, Inc. INSY has moved higher as of late, but there could definitely be trouble on the horizon for this company. That is because INSY is now in overbought territory with an RSI value ...

Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Alphabet Inc (NASD: GOOG), where a total of 8,053 contracts have traded so far, ...

As of late, it has definitely been a great time to be an investor in Insys Therapeutics Inc (INSY). The stock has moved higher by 17.3% in the past month, while it is also above its 20 Day SMA too.

The Insider Monkey team has completed processing the quarterly 13F filings for the September quarter submitted by the hedge funds and other money managers included in our extensive database. Most ...

Insys Therapeutics (INSY) closed at $4.62 in the latest trading session, marking a +1.99% move from the prior day. This move outpaced the S&P 500's daily gain of 0.67%. At the same time, the Dow added ...

Judging by the fact that Insys Therapeutics Inc (NASDAQ:INSY) has witnessed a decline in interest from the aggregate hedge fund industry, we can see that there were a few hedge funds who sold off ...

The chart below shows where INSY has traded over the past year, with the 50-day and 200-day moving averages included. Special Offer: Join the income investing conversation on ValueForum.com with a ...

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a ...

Insys Therapeutics (INSY) closed the most recent trading day at $4.81, moving +1.69% from the previous trading session. This change outpaced the S&P 500's 1.09% gain on the day. Elsewhere, the Dow ...